Comparative "real world" in vitro activity of two new antimicrobials (ceftolozane-tazobactam and ceftazidime-avibactam) against ceftazidime non-susceptible Pseudomonas aeruginosa and resistant Enterobacteriaceae from california long term acute care hospitals
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.